Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective

Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective

BackgroundEpstein-Barr virus (EBV) is the causal agent of infectious mononucleosis and has been associated with various cancers and autoimmune diseases. Despite decades of research efforts to combat this major global health burden, there is no approved prophylactic vaccine against EBV. To facilitate...

Full description

Bibliographic Details
Main Authors: Gabriela M. Escalante, Lorraine Z. Mutsvunguma, Murali Muniraju, Esther Rodriguez, Javier Gordon Ogembo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
Epstein-Barr virus
infectious mononucleosis
cancer
prophylactic vaccine
glycoprotein
neutralizing antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.867918/full

Similar Items

Similar Items